日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharma association issues report on innovative drugs

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-04-21 17:44
Share
Share - WeChat
The Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment held an event on Tuesday to release a report on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative. [Photo provided to chinadaily.com.cn]

A total of 200 innovative drugs have been approved in China over the past five years, among which many have been included in public-funded medical insurance programs, according to a recent report by the Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment.

Focusing on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative, the report said about 33 percent of innovative drugs approved in the past five years are tumor treatments, and about 80 percent of the drugs, or 156 titles, are from multinational pharmaceutical companies.

The innovative drugs registered by multinational pharmaceutical companies have also showed more diversity in the past five years, as the share of tumor treatments has dropped to 33 percent from 47 percent in the period from 2010 to 2015, while more drugs for diseases related to the nervous system, digestion and the cardiovascular and respiratory systems have been registered.

Yang Ying, vice-president of Worldwide Business Development Asia at US-based pharmaceutical company Pfizer, said foreign pharmaceutical enterprises see China not only as an important market, but also an important investment destination for both commercialization and research and development.

As Chinese enterprises show increasing innovation capabilities, there are more cooperation opportunities for foreign and domestic enterprises in pharmaceutical industry, she said.

However, high costs and patients' lack of access to innovative drugs still remain a problem for the innovative pharmaceutical industry in China, according to the report.

Innovative drugs only account for about 9 percent of the total pharmaceutical market in China, the world's second-largest pharmaceutical market in the world, while in other G20 member countries the figure is all above 20 percent, and in developed countries such as the United States, Japan and Germany, the figure is more than 50 percent.

Kang Wei, managing director of RDPAC, suggested promoting the development of commercial insurance to increase the accessibility of innovative drugs and thus better meet Chinese patients' clinical demands.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 高清一区二区三区 | 成人在线精品 | 免费成人在线网站 | 午夜精品一区二区三区在线视频 | 青草青草久热精品视频在线网站 | 免费看黄网站在线 | 亚洲第一页在线视频 | 日本三级理论 | 日韩精品成人 | 国产色视频一区 | 久久国产日韩 | 国产一区在线免费观看 | 91日日| 久草网站在线 | 四虎1515hh海外永久免费在线 | 久草视频官网 | 無码一区中文字幕少妇熟女H | 国产精品爽爽va在线观看网站 | 草综合| 欧美一区二区三区在线播放 | 91短视频社区在线观看 | 久久久精选 | 日韩一区二区在线观看 | 91精品中文字幕 | 中文字幕乱码视频32 | 午夜精品一区二区三区免费视频 | 国产精品免费一级在线观看 | 亚洲欧美国产高清 | 亚洲欧洲视频 | 91av在线免费视频 | 欧美日韩精品一区二区三区蜜桃 | 亚洲欧美日韩在线线精品 | 国产精品揄拍100视频最近 | 亚洲欧美电影 | 久草中文在线 | 色网站免费视频 | 美美女高清毛片视频免费观看 | 久久中文字幕不卡一二区 | 亚洲欧美中文日韩综合 | 在线免费国产 | 亚洲天堂久久 |